Market Place
Sourcing Support
All News #Library
Celltrion’s Biologics Avtozma Receives Approval in US
21 Jan 2026 //
FDA
Celltrion’s Biologics Eydenzelt Receives Approval in US
02 Oct 2025 //
FDA
Celltrion’s Biologics Stoboclo Receives Suppl Approval in US
10 Sep 2025 //
FDA
Celltrion’s Biologics Osenvelt Receives Suppl Approval in US
10 Sep 2025 //
FDA
Celltrion Healthcare`s Qoyvolma Receives Approval in Europe
02 Jun 2025 //
EMA
Celltrion`s Biologics Herzuma Receives Suppl Approval in US
22 May 2025 //
FDA
Celltrion`s Biologic Steqeyma Receives Suppl Approval in US
28 Apr 2025 //
FDA
Celltrion`s Biologic Stqeyma Receives Suppl Approval in US
17 Dec 2024 //
FDA
Celltrion`s Biologic Herzuma Receives Suppl Approval in US
14 Nov 2024 //
FDA
Celltrion`s Steqeyma (ustekinumab) Receives Approval in Europe
11 Sep 2024 //
EMA
Celltrion Healthcare`s Omlyclo (omalizumab) Receives Approval in the Europe
29 May 2024 //
EMA
Celltrion`s Biologic Yuflyma (adalimumab) Receives Approval in the U.S.
30 Nov 2023 //
FDA
Celltrion`s Biologic Zymfentra (infliximab) Receives Approval in the U.S.
20 Oct 2023 //
FDA
Celltrion`s Biologic Yuflyma (Adalimumab) Receives Approval in the U.S.
06 Sep 2023 //
FDA
Celltrion`s Regkirona regdanvimab Receives Approval in Europe
25 Aug 2023 //
EMA
Celltrion`s Yuflyma (adalimumab) Receives Approval in Europe
18 Jul 2023 //
EMA
Celltrion`s Biologic Yuflyma (Adalimumab) Receives Approval in the U.S.
23 May 2023 //
FDA
Celltrion Healthcare`s Vegzelma (bevacizumab) Receives Approval in Europe
22 Mar 2023 //
EMA
Celltrion`s Biologic Vegzelma (Bevacizumab) Receives Approval in the U.S.
27 Sep 2022 //
FDA
Celltrion`s Biologic Truxima (Rituximab-abbs) Receives Approval in the U.S.
04 Feb 2022 //
FDA
Celltrion`s Regkirona (regdanvimab) Receives Approval in Europe
12 Nov 2021 //
EMA
Celltrion`s Generics Deferasirox Receives Approval in US
30 May 2021 //
FDA
Celltrion`s Generics Pregabalin Receives Approval in US
26 Mar 2020 //
FDA
Celltrion`s Truxima (Rituximab-Abbs) Receives Supplemental Approval in US
30 May 2019 //
FDA
Celltrion`s Generics Linezolid Receives Approval in US
30 Apr 2019 //
FDA
Celltrion`s Biological Rituximab-Abbs Receives Approval in US
28 Nov 2018 //
FDA
Celltrion`s Biological Rituximab-Abbs Receives Approval in US
28 Nov 2018 //
FDA
Celltrion`s Inflectra (Infliximab-Dyyb) Receives Supplemental Approval in US
28 Jul 2018 //
FDA
Celltrion Healthcare Hungary Kft Gets EU Nod For Truxima (Rituximab)
08 Mar 2017 //
EMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.